Form 4: Solstice CFO Reports RSU Dividend Equivalents
Insider Transaction Report
Solstice Advanced Materials Inc.'s SVP and CFO, Tina Pierce, reported the acquisition of restricted stock units through dividend equivalent rights and updated her beneficial ownership of common stock and derivative securities.
Summary
- Tina Pierce, SVP and CFO of Solstice Advanced Materials Inc. (SOLS), reported changes in her beneficial ownership of company securities.
- The filing indicates the acquisition of various Restricted Stock Units (RSUs) on March 10, 2026, as dividend equivalent rights.
- These RSUs have varying vesting schedules, with some vesting in single installments and others in multiple installments over several years, subject to continued employment.
- Beneficial ownership of common stock following these transactions is 5,692 shares.
- The filing also details existing stock options with exercise prices ranging from $44.95 to $50.59, and expiration dates between February 2032 and March 2035.
- Some stock options are fully vested, while others vest in installments through March 2029.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral-to-slightly positive filing. It is a routine insider transaction report reflecting dividend equivalent rights and existing equity awards, which generally indicates continued management alignment but no new significant investment decision or operational news.
Positives
- The acquisition of Restricted Stock Units (RSUs) through dividend equivalent rights increases the reporting person's equity stake, aligning management interests with shareholders.
- The continued holding of significant stock options provides long-term incentives for the SVP and CFO to enhance company performance.
Future Outlook
The future outlook for Tina Pierce's equity holdings includes the vesting of various Restricted Stock Units on specific dates between July 2026 and October 2029, and the continued exercisability and vesting of stock options through March 2029, with expiration dates extending to March 2035.
Industry Context
StockSavvy.ai notes that routine Form 4 filings, particularly those reporting the acquisition of dividend equivalent rights on existing equity awards, are common for executives of publicly traded companies. These filings generally reflect standard compensation practices and the ongoing alignment of management's financial interests with those of shareholders, rather than indicating new strategic initiatives or significant shifts in company direction.
Stakeholder Impact
- Shareholders: The continued equity holdings and vesting schedules for the SVP and CFO reinforce management's alignment with shareholder interests, as their compensation is tied to the company's long-term performance.
- Employees: The filing pertains to executive compensation, which may indirectly influence overall employee morale and retention strategies, particularly for other equity award holders.
Next Steps
- Vesting of 5 Restricted Stock Units on July 30, 2026.
- Vesting of 3 Restricted Stock Units on July 28, 2026.
- Vesting of 2,996 Restricted Stock Units on May 20, 2026.
- First installment of stock options with an exercise price of $46.03 vesting on February 23, 2026.
- First installment of stock options with an exercise price of $46.79 vesting on March 1, 2026.
- First installment of stock options with an exercise price of $50.59 vesting on March 3, 2026.
- Subsequent vesting of various Restricted Stock Units and stock options on their respective schedules through October 2029.
Key Dates
| Date | Description |
|---|---|
| 02/10/2032 | Expiration date for Stock Options with an exercise price of $44.95. |
| 02/22/2033 | Expiration date for Stock Options with an exercise price of $46.03. |
| 02/23/2026 | First installment of Stock Options with an exercise price of $46.03 vest and become exercisable. |
| 02/23/2027 | Second installment of Stock Options with an exercise price of $46.03 vest and become exercisable. |
| 02/24/2027 | 33% of Restricted Stock Units (from the 10 RSU grant) vest. |
| 02/24/2028 | 33% of Restricted Stock Units (from the 10 RSU grant) vest. |
| 02/24/2029 | 34% of Restricted Stock Units (from the 10 RSU grant) vest. |
| 02/28/2034 | Expiration date for Stock Options with an exercise price of $46.79. |
| 03/01/2026 | First installment of Stock Options with an exercise price of $46.79 vest and become exercisable. |
| 03/01/2027 | Second installment of Stock Options with an exercise price of $46.79 vest and become exercisable. |
| 03/01/2027 | 6 Restricted Stock Units vest. |
| 03/01/2028 | Third installment of Stock Options with an exercise price of $46.79 vest and become exercisable. |
| 03/02/2035 | Expiration date for Stock Options with an exercise price of $50.59. |
| 03/03/2026 | First installment of Stock Options with an exercise price of $50.59 vest and become exercisable. |
| 03/03/2027 | Second installment of Stock Options with an exercise price of $50.59 vest and become exercisable. |
| 03/03/2028 | Third installment of Stock Options with an exercise price of $50.59 vest and become exercisable. |
| 03/03/2028 | 5 Restricted Stock Units vest. |
| 03/03/2029 | Fourth installment of Stock Options with an exercise price of $50.59 vest and become exercisable. |
| 03/10/2026 | Date of earliest transaction, involving the acquisition of dividend equivalent Restricted Stock Units. |
| 05/20/2026 | 2,996 Restricted Stock Units (from the 9 RSU grant) vest. |
| 05/20/2027 | 2,992 Restricted Stock Units (from the 9 RSU grant) vest. |
| 05/20/2028 | 3,087 Restricted Stock Units (from the 9 RSU grant) vest. |
| 07/28/2026 | 3 Restricted Stock Units vest. |
| 07/29/2027 | 3 Restricted Stock Units vest. |
| 07/30/2026 | 5 Restricted Stock Units vest. |
| 10/30/2028 | First equal installment of 30 Restricted Stock Units vest. |
| 10/30/2029 | Second equal installment of 30 Restricted Stock Units vest. |
Keywords
Solstice Advanced Materials, SOLS, Tina Pierce, SVP and CFO, Form 4, Insider Transaction, Restricted Stock Units, RSU, Stock Options, Beneficial Ownership, Dividend Equivalent Rights
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.